Performance of two modified two-tier algorithms for the serologic diagnosis of Lyme disease
Journal of Clinical Microbiology · 2024
DOI: 10.1128/jcm.00139-24 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Clinical Microbiology, 2024. Verfasst von Marie L Landry und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Yale University School of Medicine, New Haven, Connecticut, USA. Hauptthemen laut MEDLINE: Lyme Disease, Algorithms, Immunoglobulin M, Immunoglobulin G. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS.
Abstract (Originalsprache)
We compared the performance of a new modified two-tier testing (MTTT) platform, the Diasorin Liaison chemiluminescent immunoassay (CLIA), to the Zeus enzyme-linked immunoassay (ELISA) MTTT and to Zeus ELISA/Viramed immunoblot standard two-tier testing (STTT) algorithm. Of 537 samples included in this study, 91 (16.9%) were positive or equivocal by one or more screening tests. Among these 91 samples, only 57 samples were concordant positive by first-tier screening tests, and only 19 of 57 were concordant by the three second-tier methods. For IgM results, positive percent agreement (PPA) was 68.1% for Diasorin versus 89.4% for Zeus compared to immunoblot. By contrast, the PPA for IgG for both Diasorin and Zeus was 100%. Using a 2-out-of-3 consensus reference standard, the PPAs for IgM were 75.6%, 97.8%, and 95.6% for Diasorin, Zeus, and immunoblot, respectively. The difference between Zeus MTTT and Diasorin MTTT for IgM detection was significant ( P = 0.0094). PPA for both Diasorin and Zeus MTTT IgG assays was 100% but only 65.9% for immunoblot STTT ( P = 0.0005). In total, second-tier positive IgM and/or IgG results were reported for 57 samples by Diasorin MTTT, 63 by Zeus MTTT, and 54 by Viramed STTT. While Diasorin CLIA MTTT had a much more rapid, automated, and efficient workflow, Diasorin MTTT was less sensitive for the detection of IgM than Zeus MTTT and STTT including in 5 early Lyme cases that were IgM negative but IgG positive. IMPORTANCE The laboratory diagnosis of Lyme disease relies upon the detection of antibodies to Borrelia species. Standard two tier testing (STTT) methods rely upon immunoblots which have clinical and technical limitations. Modified two-tier testing (MTTT) methods have recently become available and are being widely adopted. There are limited independent data available assessing the performance of MTTT and STTT methods.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
- Department of Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
- Yale New Haven Hospital, New Haven, Connecticut, USA.
ORCID-Profile: Marie L Landry, David R Peaper
Förderung
- NCATS NIH HHS
Zitieren
APA
Landry, M. L., Hassan, S., Rottmann, B. G., Pesak, S. J., Ordazzo, M., Skrzyniarz, M., Deponte, S., & Peaper, D. R. (2024). Performance of two modified two-tier algorithms for the serologic diagnosis of Lyme disease. Journal of Clinical Microbiology. https://doi.org/10.1128/jcm.00139-24
Vancouver
Landry ML, Hassan S, Rottmann BG, Pesak SJ, Ordazzo M, Skrzyniarz M, et al. Performance of two modified two-tier algorithms for the serologic diagnosis of Lyme disease. Journal of Clinical Microbiology. 2024. doi:10.1128/jcm.00139-24
BibTeX
@article{Landry2024,
author = {Landry, Marie L and Hassan, Sajjad and Rottmann, Bruce G and Pesak, Stacey J and Ordazzo, Michael and Skrzyniarz, Michael and Deponte, Steven and Peaper, David R},
title = {Performance of two modified two-tier algorithms for the serologic diagnosis of Lyme disease},
journal = {Journal of Clinical Microbiology},
year = {2024},
doi = {10.1128/jcm.00139-24}
}
EUVIMED